Welcome to Explant or Bust!
Important Allergan & McGhan Textured Saline and Silicone Breast Implant Recall
The FDA finally asked Allergan (formerly McGhan) to voluntarily recall certain textured saline and silicone breast implants that were implicated in causing Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).
McGhan implants ARE part of the recall.
Both saline and silicone-filled implants are recalled, because it is the textured surface (not the filling material) that is allegedly causing an autoimmune response which leads to Breast Implant Associated-Anaplastic Large Cell Lymphoma (BIA-ALCL), Breast Implant Associated-Squamous Cell Carcinoma (BIA-SCC) and other Breast Implant Associated cancers.
Plastic Surgery Foundation Profile Registry
The PROFILE Registry is open to all physicians in the United States who have a patient with breast implants that has a suspected or confirmed case of Breast Implant-Associated ALCL (BIA-ALCL), Breast Implant Associated Squamous Cell Carcinoma (BIA-SCC) or any lymphoma or other cancer found in the capsule surrounding the breast implant.
PROFILE Case Submission Form – Report A Case
National Breast Implant Registry (Device Tracking App)
United States Food and Drug Administration (FDA) Textured Breast Implant Safety Communications (links below)
- Allergan (McGhan) Voluntarily Recalls BIOCELL® Textured Breast Implants and Tissue Expanders
- U.S. Food & Drug Administration – What to Know About Breast Implants
- U.S. Food & Drug Administration – Risks and Complications of Breast Implants
- FDA takes action to protect patients from risk of certain textured breast implants; requests Allergan voluntarily recall certain breast implants and tissue expanders from market
- U.S. Food & Drug Administration – Medical Device Reports of Breast Implant-Associated Anaplastic Large Cell Lymphoma
- U.S. Food & Drug Administration – Medical Device Reports for Systemic Symptoms in Women with Breast Implants
- U.S. Food & Drug Administration – Labeling for Approved Breast Implants
- U.S. Food & Drug Administration – Questions and Answers about Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)
- U.S. Food & Drug Administration – MedWatch Online Voluntary Reporting Form
- U.S. Food & Drug Administration – Things to Consider Before Getting Breast Implants
- U.S. Food & Drug Administration – FDA Strengthens Breast Implant Safety Requirements
- U.S. Food & Drug Administration – FDA Strengthens Safety Requirements and Updates Study Results for Breast Implants
- Government of Canada – Health Canada will be Updating Its Safety Review of Breast Implants
- UK Government – Guidance: Breast Implant Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)
- Australian Government – Breast Implants and Anaplastic Large Cell Lymphoma Update – Suspended Breast Implant Devices Now Cancelled
- The 2016 revision of the World Health Organization Classification of Lymphoid Neoplasms
Trusted Resources
Breast Implant Safety Alliance (BISA)
Reversing Breast Implant Illness
Knowledge is Beautiful.
Breast Implant Safety Alliance
Take action
Know Your Breast Implant Type and Manufacturer
I strongly recommend going back to your doctor to find out the information about your implants NOW. You should have been given the Medical Device Registration Card at surgery.
Even if it is past the 7 years that the surgeon is required to keep your records (in the US), ASK them before more time passes.
Consider Legal Action
If you are explanting, request the official, legal chain of custody for your implants IN WRITING PRIOR TO SURGERY. My own explant surgeons ignored this request, so follow up immediately after surgery. Ensure that you know who has your implants and where they are being stored. My explant surgeon, at the self-reported third busiest office in the US, did not even know that the hospital laboratory routinely destroys the implants as medical waste two weeks after surgery.
Breast Implant Associated-Anaplastic Large Cell Lymphoma (BIA-ALCL) Lawsuits
Breast Implant Illness (BII) Lawsuits
Contact: Megan McBride, Esq. PLLC (Attorney at Law)
Telephone: 850-860-1677
Email: mmcbride@mcbrideesq.com
While I am not advertising for Megan, she is one of several attorneys filing class action and individual cases. Megan has been working on this issue longer than many of the attorneys working on breast implant injuries.
Megan filed a class action complaint against Allergan for injuries associated with the increased risk of BIA-ALCL. She is also pursuing individual cases for women who have suffered injuries after July 24, 2019, as a result of recalled breast implants. Individual cases include women who have been diagnosed with BIA-ALCL. Megan is investigating cases against all breast implant manufacturers and is watching the FDA updates closely.
A comprehensive list of ongoing litigation, attorneys filing cases, and legal updates can be found at the following 2 reputable websites linked below. As both of these sites are maintaining up-to-date information, I will not be repeating that information on this site.